The 6 Most Shorted Nasdaq Stocks

Print Email

Mattel Inc. (NASDAQ: MAT) saw the number of its shares short grow for the ninth consecutive period, most recently by nearly 7%. The more than 76.79 million shares reported for the end of last month represented 22.4% of the toymaker’s total float, and it was the highest number in the past year. As the average daily trading volume surged, days to cover fell from almost 10 to less than three in the period.

The toy maker offered up disappointing quarterly results between the settlement dates. In the final two weeks of last month, Mattel shares dropped more than 10%, and they retreated even further afterward. The most recent closing stock price was $13.93, which is down about 38% in the past six months. In the past year, the shares have traded between $12.71 and $32.48 apiece.

Synergy Pharmaceuticals

Short interest at Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) totaled over 68.88 million shares on October 31, after a gain of a bit more than 3% from on the prior settlement date. That represented a whopping 30.7% of the total float and was the greatest level of short interest so far this year. The days to cover dropped from less than 10 to more than 12 during the latest period as the average daily volume shrank.

This biopharmaceutical company is focused on treatments for constipation and irritable bowel syndrome. Short sellers watched the stock pull back more than 14% but then recover just a little by the conclusion of those two weeks. The most recent closing share price was $2.97, which is more than 26% lower than it was six months ago. The shares have changed hands between $2.56 and $7.15 apiece in the past year.

Opko Health

Opko Health Inc.’s (NASDAQ: OPK) short interest retreated more than 10% from in the previous period to more than 63.99 million shares on the most recent settlement date. That was the first time since January that it was less than 70 million, and it represented 19.4% of the total float. The daily average trading volume continued to decline, but the days to cover number ticked down to less than 19.

For well more than a year, the CEO frequently has bought batches of Opko shares. The stock closed most recently at $5.41 a share, in a 52-week trading range of $5.35 to $12.15. By the end of the two-week short-interest period, the share price was a little more than 3% lower. It has retreated much more than that since then. The stock currently is more than 10% lower than it was six months ago.

And Others

Rounding out the top 10 were Comcast Corp. (NASDAQ: CMCSA), TherapeuticsMD Inc. (NASDAQ: TXMD), Microsoft Corp. (NASDAQ: MSFT) and Micron Technology Inc. (NASDAQ: MU). The big mover here was the women’s health-focused company, TherapeuticsMD, with a more than 35% jump in short interest. Note that the stock only recently began trading on the Nasdaq.

Comcast, on the other hand, saw the number of its shares short shrink by about 12%. Cisco Systems Inc. (NASDAQ: CSCO) slipped out of the top 10 with a modest decline in its short interest. Meanwhile, Inc. (NASDAQ: JD) also saw a double-digit percentage rise in short interest, but that  was not enough to lift it into the top 10 most shorted Nasdaq stocks last month.